Share
CNBC Pro

Eli Lilly CEO on Alzheimer's drug candidate update, Covid antibody treatment

Eli Lilly CEO Dave Ricks joined Jim Cramer on "Mad Money" to discuss promising results from an Alzheimer's drug study, the company's Covid-19 antibody treatment program and migraine product.
12:36
Mon, Feb 22 20217:15 PM EST

watch now
VIDEO08:26
CNBC ProBessemer's Byron Deeter on the winners in the tech sector
watch now
VIDEO01:27
CNBC ProCramer says he is 'addicted' to these five retailers, including Costco and Target
watch now
VIDEO06:06
CNBC ProHere's why BNY Mellon's Alicia Levine expects 'hiccups' in the bond market
watch now
VIDEO04:40
CNBC ProMario Gabelli's full interview on the most important points in Buffett's 2021 letter
watch now
VIDEO14:07
CNBC ProWatch CNBC's full interview with J&J CEO Alex Gorsky on the single-shot Covid vaccine rollout